Home > Insider Trading > Filing (0001209191-21-028737)

Filing Details

Accession Number:: 0001209191-21-028737
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-27 20:19:07
Reporting Period:: 2021-04-23

Accepted Time:: 2021-04-27 20:19:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
860730	Hca Healthcare Inc.	HCA	Services-General Medical & Surgical Hospitals, Nec (8062)	273865930

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1373493	B Jonathan Perlin	One Park Plaza Nashville TN 37203	Pres-Clinical Operations & Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-23	24,000	$68.96	86,819	No	4	M	Direct
Common Stock	Acquisiton	2021-04-23	23,910	$69.58	110,729	No	4	M	Direct
Common Stock	Acquisiton	2021-04-23	25,680	$81.96	136,409	No	4	M	Direct
Common Stock	Acquisiton	2021-04-23	24,015	$101.16	160,424	No	4	M	Direct
Common Stock	Acquisiton	2021-04-23	9,330	$139.06	169,754	No	4	M	Direct
Common Stock	Acquisiton	2021-04-23	5,520	$145.24	175,274	No	4	M	Direct
Common Stock	Disposition	2021-04-23	74,065	$202.50	101,209	No	4	F	Direct
Common Stock	Disposition	2021-04-23	37,305	$200.03	63,904	No	4	S	Direct
Common Stock	Disposition	2021-04-27	25,000	$0.00	32,802	No	5	G	Indirect	By DJP 2020 Trust
Common Stock	Acquisiton	2021-04-27	25,000	$0.00	25,000	No	5	G	Indirect	By Spouse
Common Stock	Disposition	2021-04-27	25,000	$0.00	0	No	5	G	Indirect	By Spouse
Common Stock	Acquisiton	2021-04-27	25,000	$0.00	88,904	No	5	G	Direct
Common Stock	Disposition	2021-04-27	25,000	$0.00	63,904	No	5	G	Direct
Common Stock	Acquisiton	2021-04-27	25,000	$0.00	25,000	No	5	G	Indirect	By 2021 Trust
Common Stock	Disposition	2021-04-27	25,000	$200.08	0	No	4	S	Indirect	By 2021 Trust
Common Stock	Disposition	2021-04-27	38,390	$199.91	25,514	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	5	G	Indirect	By DJP 2020 Trust
No	5	G	Indirect	By Spouse
No	5	G	Indirect	By Spouse
No	5	G	Direct
No	5	G	Direct
No	5	G	Indirect	By 2021 Trust
No	4	S	Indirect	By 2021 Trust
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Right	Disposition	2021-04-23	24,000	$0.00	24,000	$68.96
Common Stock	Stock Appreciation Right	Disposition	2021-04-23	23,910	$0.00	23,910	$69.58
Common Stock	Stock Appreciation Right	Disposition	2021-04-23	25,680	$0.00	25,680	$81.96
Common Stock	Stock Appreciation Right	Disposition	2021-04-23	24,015	$0.00	24,015	$101.16
Common Stock	Stock Appreciation Right	Disposition	2021-04-23	9,330	$0.00	9,330	$139.06
Common Stock	Stock Appreciation Right	Disposition	2021-04-23	5,520	$0.00	5,520	$145.24

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2025-02-04	No	4	M	Direct
0	2026-01-29	No	4	M	Direct
0	2027-02-01	No	4	M	Direct
8,005	2028-01-31	No	4	M	Direct
9,330	2029-01-30	No	4	M	Direct
16,560	2030-01-29	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	57,802	Indirect	By JBP 2020 Trust
Common Stock	1,182	Indirect	By 2011 GRAT
Common Stock	3,846	Indirect	By 2012 GRAT

Footnotes

Includes 2,068.9415 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.50, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.395, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.50 to $200.00, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.
The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.
The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020.
The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021.